Coronary Stents Market
Market Size in USD Billion
CAGR :
% 
 Forecast Period |
1 –2028 |
 Market Size (Base Year) |
|
 Market Size (Forecast Year) |
USD 30.23 Billion |
 CAGR |
% |
| Major Markets Players |
|
Global Coronary Stents Market, By Type (Dual Therapy Stent, Bioabsorbable Vascular Scaffold, Drug Eluting Stent (DES), Bio-Engineered Stent and Bare Metal Stent), Absorption Rate (Slow-Absorption DES and Fast-Absorption (DES)), Material (Stainless Steel, Cobalt Alloy Metal, Gold, Tantalum, Nitino and Polymers), Rate (Slow-Absorption Stents and Fast-Absorption Stents), Application (Coronary Artery Disease and Peripheral Artery Disease), Mode Of Delivery (Balloon-expandable Stents and Self-expanding Stents), End Users (Hospitals, Cardiac Centres and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights of Coronary Stents Market
Rise in the prevalence of angioplasty surgeries coupled with the rising geriatric population is promoting the coronary stents market value. Data Bridge Market Research analyses that the coronary stents market will exhibit a CAGR of around 7.34% for the forecast period of 2021-2028.
Coronary stents are the expandable mesh tubes that are inserted into the coronary arteries to regulate to flow or the supply of blood. It is used during a surgical process to keep the arteries open and prevent them from getting blood clogged. The coronary stents are made of medical-grade steel and once inserted, stay in the arteries permanently. This is because the tissues will start to coat the stent-like layer of the skin itself. Coronary stents are used in almost every angioplasty nowadays.
With the rising number of patients with heart-related diseases, the demand for coronary stents has significantly gone up. The rising geriatric population coupled with rising cardiovascular diseases and diabetic patients have led to the rise in demand for coronary stents. The low rate of risks involved coupled with the low cost of manufacturing has also propelled the demand for coronary stents.
Complications involved in the insertion of a stent will slow down the rate of market growth. The high cost of undergoing the procedure of implantation will further restrict the scope of growth. The recent coronavirus outbreak has also negatively impacted the market.
This coronary stents market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on coronary stents market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Coronary Stents Market Scope and Market Size
The coronary stents market is segmented on the basis of type, absorption rate, material, rate, application, mode of delivery and end users. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of type, the coronary stents market is segmented into dual therapy stent, bioabsorbable vascular scaffold, drug eluting stent (DES), bio-engineered stent and bare metal steel. Drug Eluting Stent (DES) is further sub-segmented into paclitaxel and limus-based drugs.
- On the basis of absorption rate, the coronary stents market is segmented into slow-absorption DES and fast-absorption DES.
- On the basis of material, the coronary stents market is segmented into stainless steel, cobalt alloy metal, gold, tantalum, nitino and polymers.
- On the basis of rate, the coronary stents market is segmented into slow absorption stents and fast-absorption stents.
- The coronary stents market is also segmented on the basis of application into coronary artery disease and peripheral artery disease.
- On the basis of mode of delivery, the coronary stents market is segmented into balloon-expandable stents and self-expanding stents.
- The market is also segmented on the basis of end users into hospitals, cardiac centres and others.
Coronary Stents Market Country Level Analysis
The coronary stents market is analysed and market size insights and trends are provided by country, type, absorption rate, material, rate, application, mode of delivery and end users as referenced above.
The countries covered in the coronary stents market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the coronary stents market owing to the growing prevalence of cardiovascular diseases. Also, good level of healthcare infrastructure coupled with the increased research and development proficiencies have fostered the growth of the market in this region. Asia-Pacific on the contrary will exhibit the highest growth rate during the forecast period owing to the rising angioplasty surgeries in this region. Rising diabetic patients coupled with bad lifestyle choices such as drinking and smoking have also bolstered the market growth.
The country section of the coronary stents market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Coronary Stents Market Share Analysis
The coronary stents market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to coronary stents market.
The major players covered in the coronary stents market report are Medtronic, Abbott., Boston Scientific Corporation or its affiliates., BIOTRONIK SE & Co KG, B. Braun Melsungen AG, Terumo Corporation, STENTYS SA, MicroPort Scientific Corporation., Meril Life Sciences Pvt. Ltd., Vascular Concept., W. L. Gore & Associates, Inc., BD., ENDOLOGIX LLC., Translumina., JOTEC GmbH, Lombard Medical, Xcell Medical Group, Cardinal Health., Cook and Sahajanand Laser Technology Limited (SLTL Group) among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1. INTRODUCTION
1.1. OVERVIEW OF THE GLOBAL CORONARY STENTS MARKET
1.2. MARKET SEGMENTATION & COVERAGE
1.2.1. CURRENCY AND PRICING
1.2.2. LIMITATION
1.2.3. STAKEHOLDERS
2. RESEARCH METHODOLOGY
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE GLOBAL CORONARY STENTS MARKET SIZE
2.2.1. MARKET CRACKDOWN APPROACH
2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
2.2.3. DATA TRIANGULATION
2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES
2.2.6. PORTER’S FIVE FORCES MATRIX
2.3. GLOBAL CORONARY STENTS MARKET: RESEARCH SNAPSHOT
2.4. ASSUMPTIONS
3. MARKET LANDSCAPE SUMMARY
4. PREMIUM INSIGHTS
4.1. OVERVIEW
4.2. GLOBAL CORONARY STENTS MARKET: KEY PRIMARY INSIGHTS
4.3. MARKET OVERVIEW
4.3.1. DRIVERS
4.3.2. RESTRAINTS
4.3.3. OPPOTUNITIES
4.3.4. THREATS
4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES
5. GLOBAL CORONARY STENTS MARKET, BY TYPE
5.1. OVERVIEW
5.2. DUAL THERAPY STENT
5.3. BIORESORBABLE VASCULAR SCAFFOLD
5.4. DRUG ELUTING STENT (DES)
5.4.1. PACLITAXEL
5.4.2. IMUS-BASED DRUGS
5.5. BIO-ENGINEERED STENT
5.6. BARE METAL STENT
6. GLOBAL CORONARY STENTS MARKET, BY ABSORPTION RATE
6.1. SLOW-ABSORPTION DES
6.2. FAST-ABSORPTION (DES)
7. GLOBAL CORONARY STENTS MARKET, BY MATERIAL
7.1. OVERVIEW
7.2. STAINLESS STEEL
7.3. COBALT ALLOY METAL
7.4. GOLD
7.5. TANTALUM
7.6. NITINOL
7.7. POLYMERS
8. GLOBAL CORONARY STENTS MARKET, BY RATE
8.1. OVERVIEW
8.2. SLOW-ABSORPTION STENTS
8.3. FAST-ABSORPTION STENTS
9. GLOBAL CORONARY STENTS MARKET, BY APPLICATION
9.1. CORONARY ARTERY DISEASE
9.2. PERIPHERAL ARTERY DISEASE
10. GLOBAL CORONARY STENTS MARKET, BY END USER
10.1. HOSPITALS
10.2. CARDIAC CENTERS
10.3. OTHERS
11. GLOBAL CORONARY STENTS MARKET, BY GEOGRAPHY
11.1. COUNTRYWISE CORONARY STENTS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
11.1.1. NORTH AMERICA
11.1.1.1. U.S.
11.1.1.2. CANADA
11.1.1.3. MEXICO
11.1.2. EUROPE
11.1.2.1. GERMANY
11.1.2.2. FRANCE
11.1.2.3. U.K.
11.1.2.4. ITALY
11.1.2.5. SPAIN
11.1.2.6. RUSSIA
11.1.2.7. TURKEY
11.1.2.8. BELGIUM
11.1.2.9. NETHERLANDS
11.1.2.10. SWITZERLAND
11.1.2.11. REST OF EUROPE
11.1.3. ASIA-PACIFIC (APAC)
11.1.3.1. JAPAN
11.1.3.2. CHINA
11.1.3.3. SOUTH KOREA
11.1.3.4. INDIA
11.1.3.5. AUSTRALIA
11.1.3.6. SINGAPORE
11.1.3.7. THAILAND
11.1.3.8. MALAYSIA
11.1.3.9. INDONESIA
11.1.3.10. PHILIPPINES
11.1.3.11. REST OF APAC
11.1.4. SOUTH AMERICA
11.1.4.1. BRAZIL
11.1.4.2. REST OF SOUTH AMERICA
11.1.5. MIDDLE EAST AND AFRICA
11.1.5.1. SOUTH AFRICA
11.1.5.2. REST OF MIDDLE EAST AND AFRICA
11.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
12. GLOBAL CORONARY STENTS MARKET: COMPETITIVE LANDSCAPE
12.1. GLOBAL CORONARY STENTS MARKET: COMPANY SHARE ANALYSIS
12.2. U.S. CORONARY STENTS MARKET: COMPANY SHARE ANALYSIS
12.3. EUROPE CORONARY STENTS MARKET: COMPANY SHARE ANALYSIS
12.4. APAC CORONARY STENTS MARKET: COMPANY SHARE ANALYSIS
12.5. SOUTH AMERICA CORONARY STENTS MARKET: COMPANY SHARE ANALYSIS
12.6. MIDDLE EAST AND AFRICA CORONARY STENTS MARKET: COMPANY SHARE ANALYSIS
12.7. MERGERS & ACQUISITIONS
12.8. NEW PRODUCT DEVELOPMENT & APPROVALS
12.9. EXPANSIONS
12.10. REGULATORY CHANGES
12.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
13. GLOBAL CORONARY STENTS MARKET, COMPANY PROFILES
13.1. ABBOTT VASCULAR
13.1.1. OVERVIEW
13.1.2. SWOT ANALYSIS
13.1.3. PRODUCT PORTFOLIO
13.1.4. REVENUE ANALYSIS
13.1.5. ANALYSTS VIEW
13.2. SCITECH
13.2.1. OVERVIEW
13.2.2. SWOT ANALYSIS
13.2.3. PRODUCT PORTFOLIO
13.2.4. REVENUE ANALYSIS
13.2.5. ANALYSTS VIEW
13.3. BOSTON SCIENTIFIC CORPORATION
13.3.1. OVERVIEW
13.3.2. SWOT ANALYSIS
13.3.3. PRODUCT PORTFOLIO
13.3.4. REVENUE ANALYSIS
13.3.5. ANALYST VIEW
13.4. MEDINOL LTD
13.4.1. OVERVIEW
13.4.2. SWOT ANALYSIS
13.4.3. PRODUCT PORTFOLIO
13.4.4. REVENUE ANALYSIS
13.4.5. ANALYSTS VIEW
13.5. IVASCULAR SLU
13.5.1. OVERVIEW
13.5.2. SWOT ANALYSIS
13.5.3. PRODUCT PORTFOLIO
13.5.4. REVENUE ANALYSIS
13.5.5. ANALYSTS VIEW
13.6. STENTYS SA
13.6.1. OVERVIEW
13.6.2. SWOT ANALYSIS
13.6.3. PRODUCT PORTFOLIO
13.6.4. REVENUE ANALYSIS
13.6.5. ANALYSTS VIEW
13.7. ELIXIR MEDICAL CORPORATION
13.7.1. OVERVIEW
13.7.2. SWOT ANALYSIS
13.7.3. PRODUCT PORTFOLIO
13.7.4. REVENUE ANALYSIS
13.7.5. ANALYSTS VIEW
13.8. INSPIRE MD
13.8.1. OVERVIEW
13.8.2. SWOT ANALYSIS
13.8.3. PRODUCT PORTFOLIO
13.8.4. REVENUE ANALYSIS
13.8.5. ANALYSTS VIEW
13.9. HEXACATH
13.9.1. OVERVIEW
13.9.2. SWOT ANALYSIS
13.9.3. PRODUCT PORTFOLIO
13.9.4. REVENUE ANALYSIS
13.9.5. ANALYSTS VIEW
13.10. MEDTRONIC
13.10.1. OVERVIEW
13.10.2. SWOT ANALYSIS
13.10.3. PRODUCT PORTFOLIO
13.10.4. REVENUE ANALYSIS
13.10.5. ANALYSTS VIEW
13.11. ORBUSNEICH
13.11.1. OVERVIEW
13.11.2. SWOT ANALYSIS
13.11.3 PRODUCT PORTFOLIO
13.11.4 REVENUE ANALYSIS
13.11.5 ANALYSTS VIEW
13.12. ANDRAMED GMBH
13.12.1. OVERVIEW
13.12.2. SWOT ANALYSIS
13.12.3. PRODUCT PORTFOLIO
13.12.4. REVENUE ANALYSIS
13.12.5. ANALYSTS VIEW
13.13. CORDIS CORPORATION
13.13.1. OVERVIEW
13.13.2. SWOT ANALYSIS
13.13.3. PRODUCT PORTFOLIO
13.13.4. REVENUE ANALYSIS
13.13.5. ANALYSTS VIEW
13.14. ENDOCOR GMBH
13.14.1. OVERVIEW
13.14.2. SWOT ANALYSIS
13.14.3. PRODUCT PORTFOLIO
13.14.4. REVENUE ANALYSIS
13.14.5. ANALYSTS VIEW
13.15. EUROCOR GMBH
13.15.1. OVERVIEW
13.15.2. SWOT ANALYSIS
13.15.3. PRODUCT PORTFOLIO
13.15.4. REVENUE ANALYSIS
13.15.5. ANALYSTS VIEW
13.16. COOK MEDICAL.
13.16.1. OVERVIEW
13.16.2. SWOT ANALYSIS
13.16.3. PRODUCT PORTFOLIO
13.16.4. REVENUE ANALYSIS
13.16.5. ANALYSTS VIEW
13.17. MICROPORT SCIENTIFIC CORPORATION
13.17.1. OVERVIEW
13.17.2. SWOT ANALYSIS
13.17.3. PRODUCT PORTFOLIO
13.17.4. REVENUE ANALYSIS
13.17.5. ANALYSTS VIEW
13.18. DEGANIA SILICONE LTD.
13.18.1. OVERVIEW
13.18.2. SWOT ANALYSIS
13.18.3. PRODUCT PORTFOLIO
13.18.4. REVENUE ANALYSIS
13.18.5. ANALYSTS VIEW
13.19. TERUMO CORPORATION
13.19.1. OVERVIEW
13.19.2. SWOT ANALYSIS
13.19.3. PRODUCT PORTFOLIO
13.19.4. REVENUE ANALYSIS
13.19.5. ANALYSTS VIEW
13.20. MERIL LIFE SCIENCES PVT. LTD.
13.20.1. OVERVIEW
13.20.2. SWOT ANALYSIS
13.20.3. PRODUCT PORTFOLIO
13.20.4. REVENUE ANALYSIS
13.20.5. ANALYSTS VIEW
13.21. ALVIMEDICA
13.21.1. OVERVIEW
13.21.2. SWOT ANALYSIS
13.21.3. PRODUCT PORTFOLIO
13.21.4. REVENUE ANALYSIS
13.21.5. ANALYSTS VIEW
13.22. ELIXIR MEDICAL CORPORATION
13.22.1. OVERVIEW
13.22.2. SWOT ANALYSIS
13.22.3. PRODUCT PORTFOLIO
13.22.4. REVENUE ANALYSIS
13.22.5. ANALYSTS VIEW
13.23. INSITU TECHNOLOGIES INC.
13.23.1. OVERVIEW
13.23.2. SWOT ANALYSIS
13.23.3. PRODUCT PORTFOLIO
13.23.4. REVENUE ANALYSIS
13.23.5. ANALYSTS VIEW
13.24. BIOTRONIK SE & CO. KG
13.24.1. OVERVIEW
13.24.2. SWOT ANALYSIS
13.24.3. PRODUCT PORTFOLIO
13.24.4. REVENUE ANALYSIS
13.24.5. ANALYSTS VIEW
13.25. AMG INTERNATIONAL GMBH
13.25.1. OVERVIEW
13.25.2. SWOT ANALYSIS
13.25.3. PRODUCT PORTFOLIO
13.25.4. REVENUE ANALYSIS
13.25.5. ANALYSTS VIEW
13.26. ARTHESYS
13.26.1. OVERVIEW
13.26.2. SWOT ANALYSIS
13.26.3. PRODUCT PORTFOLIO
13.26.4. REVENUE ANALYSIS
13.26.5. ANALYSTS VIEW
13.27. TRANSLUMINA GMBH
13.27.1. OVERVIEW
13.27.2. SWOT ANALYSIS
13.27.3. PRODUCT PORTFOLIO
13.27.4. REVENUE ANALYSIS
13.27.5. ANALYSTS VIEW
13.28. LEPU MEDICAL
13.28.1. OVERVIEW
13.28.2. SWOT ANALYSIS
13.28.3. PRODUCT PORTFOLIO
13.28.4. REVENUE ANALYSIS
13.28.5. ANALYSTS VIEW
13.29. ACCURA
13.29.1. OVERVIEW
13.29.2. SWOT ANALYSIS
13.29.3. PRODUCT PORTFOLIO
13.29.4. REVENUE ANALYSIS
13.29.5. ANALYSTS VIEW
13.30. CELONOVA BIOSCIENCES, INC.
13.30.1. OVERVIEW
13.30.2. SWOT ANALYSIS
13.30.3. PRODUCT PORTFOLIO
13.30.4. REVENUE ANALYSIS
13.30.5. ANALYSTS VIEW
13.31. MINVASYS
13.31.1. OVERVIEW
13.31.2. SWOT ANALYSIS
13.31.3. PRODUCT PORTFOLIO
13.31.4. REVENUE ANALYSIS
13.31.5. ANALYSTS VIEW
13.32. SVELTE MEDICAL
13.32.1. OVERVIEW
13.32.2. SWOT ANALYSIS
13.32.3. PRODUCT PORTFOLIO
13.32.4. REVENUE ANALYSIS
13.32.5. ANALYSTS VIEW
13.33. B. BRAUN MELSUNGEN AG
13.33.1. OVERVIEW
13.33.2. SWOT ANALYSIS
13.33.3. PRODUCT PORTFOLIO
13.33.4. REVENUE ANALYSIS
13.33.5. ANALYSTS VIEW
13.34. EUCATECH AG
13.34.1. OVERVIEW
13.34.2. SWOT ANALYSIS
13.34.3. PRODUCT PORTFOLIO
13.34.4. REVENUE ANALYSIS
13.34.5. ANALYSTS VIEW
13. APPENDIX
14. ABOUT DATA BRIDGE MARKET RESEARCH
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
